Loading...

PCRX PACIRA BIOSCIENCES INC Management Changes 8-K Filing

PCR

PCRX

PACIRA BIOSCIENCES INC

(PCRX)

2024 8-K

Show Summary

Show Summary

Stock Incentive Plan Approval

Financial Statements

Share Repurchase

Patent Settlement

Bylaw Amendments

Financial Results

Management Changes

Revenue Announcement

Financial Results & Changes

Management Change

Management Changes

Board Resignation

Earnings Report

Retirement of Director

Merger of Equals

Quantitative Data

Financial Results and Share...

Financial Results and CFO D...

Earnings Announcement

Appointment of CEO and Empl...

Financial Results Announcement

Appointment of Directors

Earnings Report

Annual Meeting Approval

Earnings Release

Credit Agreement Refinancin...

Departure of Directors

Earnings Announcement

Earnings Report

External Links:

Pacira BioSciences appointed Shawn M. Cross as Chief Financial Officer, effective October 21, 2024, with an annual salary of $525,000 and additional equity awards including 200,000 stock options and 75,000 restricted stock units.

AI Assistant

PACIRA BIOSCIENCES INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.